📖
A novel GWT1 A397T substitution combined with TAC1B F214I reduces manogepix susceptibility and fosmanogepix efficacy in Candida auris.
Hirayama T, Kitahori N, Ishimine M, Nakada N, Ito Y, Iwanaga N, Takazono T, Miyazaki T, Izumikawa K, Yanagihara K, Makimura K, Tsukamoto K, Mukae H

A novel GWT1 A397T substitution combined with TAC1B F214I reduces manogepix susceptibility and fosmanogepix efficacy in Candida auris.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Microbiol Spectr.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title A novel GWT1 A397T substitution combined with TAC1B F214I reduces manogepix susceptibility and fosmanogepix efficacy in Candida auris.
Author / Organization Hirayama T, Kitahori N, Ishimine M, Nakada N, Ito Y, Iwanaga N, Takazono T, Miyazaki T, Izumikawa K, Yanagihara K, Makimura K, Tsukamoto K, Mukae H
Subject & Discipline Microbiol Spectr
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-69799
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »